New study aims to protect pregnant women from HIV with extra support for taking daily prevention pills
NCT ID NCT05322629
First seen Nov 03, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study enrolls 650 HIV-negative pregnant and breastfeeding women in South Africa who are at high risk of getting HIV. Researchers are testing a program that combines daily PrEP pills with extra counseling and community delivery for those who struggle to take the pills regularly. The goal is to see if this approach helps women stay on PrEP and prevents HIV infection in both mothers and their babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gugulethu Midwife Obstetric Unit
Cape Town, South Africa, South Africa
Conditions
Explore the condition pages connected to this study.